TITLE:
Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections

CONDITION:
Diabetes Mellitus

INTERVENTION:
Piperacillin/Tazobactam

SUMMARY:

      Phase IV Open-Label Foot Infection Study is being conducted to generate comparative Efficacy
      and Safety data in Diabetic Inpatients.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

          -  Patients with diabetes mellitus

          -  Inpatient

          -  Have 1 or more infected ulcer(s) below the ankle

        Exclusion Criteria

          -  Must not have gangrene or severely impaired arterial supply in your foot

          -  Must not have a bone infection in the area of your ulcer

          -  Must not have allergies to penicillins
      
